Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity
about
Lipoprotein(a) as a cardiovascular risk factor: current statusHuman Genetics and the Causal Role of Lipoprotein(a) for Various DiseasesTranslating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitineMacrophages in the pathogenesis of atherosclerosisLipoprotein(a), inflammation, and peripheral arterial disease in a community-based sample of older men and women (the InCHIANTI study).LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiographyThe role of endoplasmic reticulum stress in the progression of atherosclerosis.Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress.Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population studyNicotinic acid inhibits hepatic APOA gene expression: studies in humans and in transgenic mice.Clinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension.Lipoprotein(a) and cardiovascular disease in diabetic patientsCorrelation analysis between serum lipoprotein (a) and the incidence of aortic valve sclerosis.Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels.Lipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease.Elevated lipoprotein (a), small apolipoprotein (a), and the risk of arterial ischemic stroke in North American children.Lipoprotein(a): a promising marker for residual cardiovascular risk assessment.Lipoprotein(a): novel target and emergence of novel therapies to lower cardiovascular disease riskAntisense technology: an emerging platform for cardiovascular disease therapeutics.Translating genomic analyses into improved management of coronary artery disease.Extended-release niacin with laropiprant : a review on efficacy, clinical effectiveness and safety.Lipoprotein(a): resurrected by genetics.New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect?Inhibition of plasminogen activation by apo(a): role of carboxyl-terminal lysines and identification of inhibitory domains in apo(a).Pathobiology of Lp(a) in calcific aortic valve disease.The metabolism of lipoprotein (a): an ever-evolving story.Structure, function, and genetics of lipoprotein (a).Significant differentiation in the apolipoprotein(a)/lipoprotein(a) trait between chimpanzees from Western and Central Africa.Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytesSecreted human apolipoprotein(a) kringle IV-10 and kringle V inhibit angiogenesis and xenografted tumor growth.HyperLp(a)lipoproteinaemia: unmet need of diagnosis and treatment?HDL-C, ABCA1-mediated cholesterol efflux, and lipoprotein(a): insights into a potential novel physiologic role of lipoprotein(a).Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a].Lipoprotein(a) in clinical practice: New perspectives from basic and translational science.Lipoprotein (a) is not significantly associated with type 2 diabetes mellitus: cross-sectional study of 1604 cases and 7983 controls.Lipoprotein (a) as a Predictor of Early Stroke Recurrence in Acute Ischemic Stroke.
P2860
Q24623225-995011DB-B6E1-4236-A2FC-D1CD895BD3D8Q28079294-99F30EAD-B608-4C38-BF8D-58FD187BD734Q28395286-03CFF982-48DD-4B3C-87E2-6088EB59C778Q29617765-E35F6403-8BA4-4848-AEF0-0B9F6A57AD8FQ33922768-912C8A46-11E3-445D-B710-D975FEF5DFE8Q33939240-BF29E361-EF40-4420-9A68-01E04D2BA0A8Q34141006-FDD73139-24FE-40FD-B016-96406C2D8B58Q34346809-3ACEF5CC-B731-480A-9F9D-EC2A61614672Q34411348-A7E7003A-B78F-41CE-93CD-219ABD7B25DBQ36302760-28DD3EF0-1E51-414F-ADD4-73A80E289764Q36359500-E828B4D9-FA1D-4BEB-BCBD-ACC08E2CB2A7Q36369444-1288185F-0A8D-492B-91E9-7DEFCF864885Q36412236-C4C99E8F-49E5-46C2-9DC9-B0F36C311D6BQ36455881-ECFF0959-179B-420C-B68D-B88B381CF8A8Q36515765-5754EC22-B5BA-4B64-BA40-CF22DA3A885EQ36805888-D143DC6C-B401-4B84-A1F0-BE18E6E8C0DCQ37285933-D185213A-8DE5-4E98-B400-C0BDBF61D8F3Q37334501-0353EBD6-D783-4E20-94FF-FE305DB9D359Q37337608-2C9CEA89-1767-47E1-9C0D-12D7ED478E0AQ37770573-057EA282-DBA8-44DE-93EC-CC1BAAC20E26Q38011204-EEDF2237-AA79-44C7-9A81-DFA573DA3BE4Q38045424-B05AC123-EFAB-4C10-A4FC-9480D58B73B6Q38126418-3D4E2650-F936-4B23-B799-CE9E9E64E6D2Q38528622-F95DC761-E845-44FC-BD8D-303E9A1464B7Q38620736-A766FC11-DDD0-43A7-B8D9-55C700FF6C36Q38655614-81CF42D8-E8F4-4DA6-8A03-1FF95C4967E5Q38807488-6C78BCB1-5A8C-49CC-93A4-D11A06A5EB48Q38849823-9CC692AD-F4A2-40C3-BC5C-3FCC178E2B42Q39860920-74419EFC-E804-426F-98FD-559F495FB880Q40029701-5A442F4B-A16B-445A-9082-425BBEFEEE93Q42396853-40E43E52-0633-4AC3-98A5-9340AE9F2B11Q42408461-345677F4-6A71-46EE-BBA8-BA9E5163A65CQ46693462-5184906D-1AAE-48DC-B859-94BF439F8D17Q47274864-B9FAFA6C-3733-4D20-AAAE-04B2389DFDEBQ48301417-91A68DE7-5C7B-41F3-9808-BEAAA2DF9487Q53617446-B58E0D49-A5D3-4F4B-8599-4E690DAD8D25
P2860
Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Structure-function relationshi ...... (a) assembly and pathogenicity
@ast
Structure-function relationshi ...... (a) assembly and pathogenicity
@en
Structure-function relationshi ...... (a) assembly and pathogenicity
@nl
type
label
Structure-function relationshi ...... (a) assembly and pathogenicity
@ast
Structure-function relationshi ...... (a) assembly and pathogenicity
@en
Structure-function relationshi ...... (a) assembly and pathogenicity
@nl
prefLabel
Structure-function relationshi ...... (a) assembly and pathogenicity
@ast
Structure-function relationshi ...... (a) assembly and pathogenicity
@en
Structure-function relationshi ...... (a) assembly and pathogenicity
@nl
P1476
Structure-function relationshi ...... (a) assembly and pathogenicity
@en
P2093
Marlys L Koschinsky
Santica M Marcovina
P304
P356
10.1097/00041433-200404000-00009
P407
P577
2004-04-01T00:00:00Z